CoQ10 (ubiquinone) is synthesized in almost all cells and membranes. It is vital for electron transfer within the mitochondrial respiratory chain to create energy in the form of ATP.
It is an important lipophilic intracellular antioxidant. Endogenous production of CoQ10 decreases with age. Low levels are implicated in age-related and chronic disease due to mitochondrial dysfunction and/or low antioxidant activity.
Supplementation with CoQ10 has been shown to prevent, and provide improvement in, neurologic conditions like Huntington’s disease, migraines, and Parkinson’s disease. It’s been extensively studied and used in metabolic and cardiovascular diseases such as congestive heart failure, hypertension, and diabetes.
Supplementation is also associated with improved proinflammatory cytokine TNF-a levels.
Coenzyme Q10 decreases with use of statin medications used to lower cholesterol via inhibiting the enzyme HMG-CoA reductase. This enzyme is responsible for cholesterol as well as CoQ10 biosynthesis. This resultant CoQ10 deficiency may contribute to the development of myopathy and muscle symptoms seen commonly with statin use. Treatment with CoQ10 has been found to ameliorate these symptoms and improve well-being and functioning in daily life.
References:
https://pubmed.ncbi.nlm.nih.gov/31687097/
https://pubmed.ncbi.nlm.nih.gov/24389208/
https://pubmed.ncbi.nlm.nih.gov/29663894/
https://www.ncbi.nlm.nih.gov/books/NBK531491/
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0170172
https://www.ahajournals.org/doi/full/10.1161/JAHA.118.009835
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257126/
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.